Citius Pharmaceuticals Inc（CTXR）价格预测CTXRCitius Pharmaceuticals Inc

Alphio's CTXR stock price prediction model matches the current Citius Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.55 (-0.43%). The 1-week path is $0.56 (+1.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Citius Pharmaceuticals Inc (CTXR) appears to be a good buy right now due to its current price of $0.55, which is significantly below its 52-week high of $1.54, suggesting potential for recovery. The company has recently reported a gross margin of 79.99% in Q1 2026, indicating strong profitability on sales, and analysts project a significant upside with a price target of $4. However, the main risk is the high net loss of $28.11 million in Q2 2026, which could impact future operations.

Citius Pharmaceuticals Inc (CTXR) last closed at $0.55, losing -1.33%. These facts feed the 1-day and 1-week CTXR price prediction above.